• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本非艾滋病相关淋巴瘤中c-myc原癌基因的基因组重排

Genomic rearrangement of the c-myc proto-oncogene in non-AIDS-related lymphoma in Japan.

作者信息

Nagai M, Ikeda K, Tasaka T, Irino S

机构信息

First Department of Internal Medicine, Kagawa Medical School, Japan.

出版信息

Leukemia. 1991 Jun;5(6):462-7.

PMID:2056771
Abstract

Southern blot analysis was employed to analyze the structural alterations of the c-myc oncogene in genomic DNA derived from tumor specimens of 35 adults with pathologically classified and immunophenotyped non-AIDS-related, non-Hodgkin's lymphoma in Japan. In this study, seven cases (20%), including one peripheral T-cell lymphoma and six B-cell lymphomas of various histological types, were demonstrated to have additional c-myc fragments. An interesting feature is that c-myc rearrangements were found in three out of eight primary gastrointestinal lymphomas. Analyses with several restriction enzymes revealed that the breakpoints in these cases were clustered in a region spanning the first exon, first intron and nearby 5'-flanking sequences of the c-myc gene, suggesting that the alteration of this region may represent an important molecular event in activating the oncogenic potential of the c-myc gene.

摘要

采用Southern印迹分析,对来自日本35例经病理分类和免疫表型分析的非艾滋病相关、非霍奇金淋巴瘤成年患者肿瘤标本的基因组DNA中c-myc癌基因的结构改变进行分析。在本研究中,7例(20%),包括1例外周T细胞淋巴瘤和6例不同组织学类型的B细胞淋巴瘤,被证实有额外的c-myc片段。一个有趣的特征是,在8例原发性胃肠道淋巴瘤中有3例发现了c-myc重排。用几种限制性内切酶进行分析显示,这些病例中的断点聚集在一个跨越c-myc基因第一外显子、第一内含子和附近5'侧翼序列的区域,这表明该区域的改变可能代表激活c-myc基因致癌潜能的一个重要分子事件。

相似文献

1
Genomic rearrangement of the c-myc proto-oncogene in non-AIDS-related lymphoma in Japan.日本非艾滋病相关淋巴瘤中c-myc原癌基因的基因组重排
Leukemia. 1991 Jun;5(6):462-7.
2
Rearrangement of the 5' cluster region of the BCL2 gene in lymphoid neoplasm: a summary of nine cases.BCL2基因5'簇区域在淋巴肿瘤中的重排:9例总结
Leukemia. 1996 Jun;10(6):970-7.
3
Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster.中心细胞淋巴瘤中染色体t(11;14)(q13;q32)断点高度定位于bcl-1主要易位簇。
Leukemia. 1993 Sep;7(9):1437-40.
4
p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines.人类非霍奇金淋巴瘤细胞系中的p53突变、c-myc和bcl-2重排
Leuk Lymphoma. 1995 Sep;19(1-2):165-71. doi: 10.3109/10428199509059672.
5
A genotypic study of low grade B-cell lymphomas, including lymphomas of mucosa associated lymphoid tissue (MALT).
J Pathol. 1990 Oct;162(2):135-40. doi: 10.1002/path.1711620206.
6
Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.B细胞非霍奇金淋巴瘤中Bcl-1、Bcl-2、Bcl-6、c-myc、p53和p16基因的单发性及相关性病变检测:分子分析对更准确划分组织学亚型的价值
Haematologica. 1998 Mar;83(3):209-16.
7
[Detection of bcl-2/JH gene rearrangements in non-Hodgkin's lymphomas and chronic tonsillitis, but not in Hodgkin's lymphomas. Molecular genetic and immunohistochemical study].[非霍奇金淋巴瘤和慢性扁桃体炎中bcl-2/JH基因重排的检测,但霍奇金淋巴瘤中未检测到。分子遗传学和免疫组织化学研究]
Pathologe. 1993 Dec;14(6):302-6.
8
Clonal immunoglobulin gene rearrangements and normal T-cell receptor, bcl-2, and c-myc genes in primary cutaneous B-cell lymphomas.原发性皮肤B细胞淋巴瘤中的克隆性免疫球蛋白基因重排及正常T细胞受体、bcl-2和c-myc基因
Cancer Res. 1989 Sep 1;49(17):4901-5.
9
Analysis of BCL2 and MYC expression in non-Hodgkin's lymphomas by in situ hybridization: correlation with chromosome translocations.通过原位杂交分析非霍奇金淋巴瘤中BCL2和MYC的表达:与染色体易位的相关性
Diagn Mol Pathol. 1992 Dec;1(4):221-8.
10
Cytogenetic, molecular biological and clinical study of B-cell lymphomas with 14;18 translocation in Japanese patients.日本患者中伴有14;18易位的B细胞淋巴瘤的细胞遗传学、分子生物学及临床研究
Leukemia. 1991 Dec;5(12):1069-75.